Utku B, Dönmez G, Erişgen G, Akin Ş, Demirel HA, Korkusuz F, Doral MN. Meloxicam and diclofenac do not change VEGF and PDGF-ABserum levels of platelet-rich plasma.
Turk J Med Sci 2017;
47:570-576. [PMID:
28425247 DOI:
10.3906/sag-1602-60]
[Citation(s) in RCA: 7] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/11/2016] [Accepted: 09/22/2016] [Indexed: 11/03/2022] Open
Abstract
BACKGROUND/AIM
Platelet-rich plasma (PRP) application has gained widespread interest for musculoskeletal injuries. Nonsteroidal antiinflammatory drugs are frequently used in sports medicine before and/or after PRP application. Our study seeks to determine whether serum levels of platelet-derived growth factor-AB (PDGF-AB) and vascular endothelial growth factor (VEGF) levels of PRP would be affected by nonsteroidal antiinflammatory drugs.
MATERIALS AND METHODS
Two different final concentrations of diclofenac (0.5 μg mL-1 and 2.5 μg mL-1), meloxicam (0.8 μg mL-1 and 2.0 μg mL-1), and acetylsalicylic acid (final concentration 450 μm) were obtained in separate tubes with PRPs prepared from 20 healthy male volunteers. Medicine-free PRP was the control group. Growth factors were measured using ELISA.
RESULTS
PDGF-AB and VEGF serum levels did not change with diclofenac, meloxicam, or acetylsalicylic acid addition. PDGF-AB and VEGF serum levels correlated with each other.
CONCLUSION
Diclofenac, meloxicam, and acetylsalicylic acid did not affect PDGF-AB and VEGF serum levels.
Collapse